Interview in "BioTechnologie Kursbuch No. 37"
We are happy to be featured in this year's “BioTechnologie Kursbuch”. The interview from Georg Kääb with our CEO Prof. Dr. Hartmut Juhl covers an overview on the latest insights on the oncology R&D industry, what part AI has within this and what we believe truly matters.
Hamburg, Germany (June 20, 2024) - Feature in BioTechnologie Kursbuch No. 37
“As cancer is as individual as people themselves, individual approaches to therapy are just as useful. Everything that is currently being developed has its potential justification - the decisive factor will be to use it at the right time based on individual variables and, if necessary, in appropriate combinations.” says Hartmut Juhl, when being asked about the diverse approaches in fighting cancer.
We are happy to share the “Kursbuch Biotechnologie” article (german), based on an interview with our Founder and CEO Prof. Dr. Hartmut Juhl.
For the full edition of the Biotechnology Kursbuch, please view the online version available.